Orlando, Fla.—A survey conducted with police and community organizations describing real-world experiences and outcomes using the FDA-approved naloxone 4-mg nasal spray formulation (Narcan, Adapt Pharma) shows efficacy similar to intramuscular formulations.
The poster, entitled “Use of Naloxone Nasal Spray in the Community Setting: a Survey of Use by Community Organizations,” was presented at the annual meeting of the American Academy of Pain Medicine (AAPM; abstract
MARCH 17, 2017